Mantenimiento a largo plazo con dosis bajas de fármacos antitiroideos de síntesis frente a retirada, en pacientes con hipertiroidismo de la enfermedad de Graves
Authors:
- Aurelio CayuelaACAurelio Cayuela
- Natividad García HernándezNHNatividad García Hernández
- Fernando Losada ViñauFVFernando Losada Viñau
- Miguel Ángel Mangas CruzMCMiguel Ángel Mangas Cruz
- María Asunción Martínez BroccaMBMaría Asunción Martínez Brocca
- Elena Navarro GonzálezEGElena Navarro González
- Alfonso Pumar LópezALAlfonso Pumar López
- Federico Relimpio AstolfiFAFederico Relimpio Astolfi
- Alfonso Soto MorenoAMAlfonso Soto Moreno
- Fernando Villamil FernándezFFFernando Villamil Fernández
- 1 March 2008
- journal article
- Published by Elsevier in Endocrinología y Nutrición
- Vol. 55 (3) , 123-131
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Treatment for Childhood-Onset Graves' Disease in Japan: Results of a Nationwide Questionnaire Survey of Pediatric Endocrinologists and ThyroidologistsThyroid®, 2007
- Antithyroid drug regimen for treating Graves' hyperthyroidism2005
- Antithyroid DrugsNew England Journal of Medicine, 2005
- Long‐term follow‐up study of radioiodine treatment of hyperthyroidismClinical Endocrinology, 2004
- Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long‐term prospective studyClinical Endocrinology, 1998
- Quality of Life Aspects and Costs in Treatment of Graves' Hyperthyroidism with Antithyroid Drugs, Surgery, or Radioiodine: Results from a Prospective, Randomized StudyThyroid®, 1998
- Clinical Features of Patients with Graves' Disease Undergoing Remission After Antithyroid Drug TreatmentThyroid®, 1997
- Treatment of Hyperthyroidism with a Small Single Daily Dose of Methimazole: A Prospective Long-Term Follow-Up Study.Endocrine Journal, 1997
- Occurrence of Ophthalmopathy after Treatment for Graves' HyperthyroidismNew England Journal of Medicine, 1992
- ANTITHYROID DRUGS IN THE TREATMENT OF HYPERTHYROIDISM OF Graves' DISEASE: LONG‐TERM FOLLOW‐UP OF 434 PATIENTSClinical Endocrinology, 1989